Inhibition of ATP hydrolysis as a key regulator of temozolomide resistance and migratory phenotype of glioblastoma cells-Reference-Cited by-同舟云学术

Inhibition of ATP hydrolysis as a key regulator of temozolomide resistance and migratory phenotype of glioblastoma cells

Published:2022-04 Issue: Volume:601 Page:24-30
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Scheffel Thamiris Becker,Rockenbach Liliana,Cruz Fernanda Fernandes,Kist Luiza Wilges^ORCID,Bogo Maurício Reis^ORCID,Scholl Juliete Nathali,Figueiró Fabrício,Lenz Guido,Morrone Fernanda Bueno^ORCID

Funder

Coordination of Higher Education Personnel Improvement

National Council for Scientific and Technological Development

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference52 articles.

1. Microenvironmental regulation of tumor progression and metastasis;Quail;Nat. Med.,2013

2. Tumor cell invasion in glioblastoma;Vollmann-Zwerenz;Int. J. Mol. Sci.,2020

3. Glioblastoma multiforme: the terminator;Holland;Proc. Natl. Acad. Sci. U. S. A.,2000

4. Glioblastoma multiforme: a review of therapeutic targets;Kanu;Expert Opin. Ther. Targets,2009

5. Immune evasion in cancer: mechanistic basis and therapeutic strategies;Vinay;Semin. Cancer Biol.,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Purinergic system in cancer stem cells;Purinergic Signalling;2023-11-15

2. Epigenetic regulation of temozolomide resistance in human cancers with an emphasis on brain tumors: Function of non-coding RNAs;Biomedicine & Pharmacotherapy;2023-09

3. A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma;Journal for ImmunoTherapy of Cancer;2023-08

4. P2Y12 receptor antagonism inhibits proliferation, migration and leads to autophagy of glioblastoma cells;Purinergic Signalling;2022-08-08